Position in AZN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,992,661,366
New position
Shares Held
10,103,749
first reported quarter
Ownership
0.651%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 92.60370581256522.ToString("F0")%
None 7.396294187434783.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $19,373,328,434 across 15 Drug Manufacturers - General names. AZN ranks #5 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
15,046,905 | $3,678,065,449 | |
| 2 | LLY |
ELI LILLY & Co
|
3,454,585 | $3,177,423,634 | |
| 3 | MRK |
Merck & Co., Inc.
|
21,855,101 | $2,628,950,086 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
15,526,336 | $2,163,905,435 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
10,103,749 | $1,992,661,366 | |
| 6 | ABBV |
AbbVie Inc.
|
7,798,048 | $1,695,997,449 | |
| 7 | AMGN |
Amgen Inc
|
4,571,725 | $1,608,561,432 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
15,509,999 | $940,681,432 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,992,661,366 | 10,103,749 | Shares | Defined | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||